TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs. May 5, 2006